Related Experiment Videos
Comorbidity in generalized anxiety disorder: impact and implications
1Medical Research Council Unit on Anxiety Disorders, University of Stellenbosch, Cape Town, South Africa. djs2@gerga.sun.ac.za
The Journal of Clinical Psychiatry
|June 21, 2001
Summary
Generalized anxiety disorder (GAD) frequently co-occurs with other conditions, impacting patient functioning and healthcare use. Early assessment and treatment of GAD are crucial for preventing further illness and disability.
Area of Science:
- Psychiatry
- Clinical Psychology
- Internal Medicine
Background:
- Generalized anxiety disorder (GAD) is a prevalent mental health condition.
- Comorbidity significantly influences the understanding and management of GAD.
- The interplay between GAD, somatic, and depressive symptoms is complex.
Purpose of the Study:
- To review common comorbidities associated with GAD.
- To examine the impact of GAD comorbidity on patient functioning and healthcare utilization.
- To discuss the implications of comorbidity for GAD treatment strategies.
Main Methods:
- Literature review of studies on GAD and its comorbidities.
- Analysis of the impact of comorbidity on disability and medical service use.
- Synthesis of clinical implications for assessment and early intervention.
Main Results:
- GAD frequently co-occurs with a range of other conditions, including somatic and depressive disorders.
- Comorbidity with GAD is linked to increased patient disability and higher medical utilization.
- The relationship between GAD and other conditions can be primary or secondary.
Conclusions:
- Rigorous assessment of anxiety, somatic, and depressive symptoms is essential for patients presenting with any of these complaints.
- Early identification and treatment of GAD may prevent the development of subsequent morbidities.
- Understanding comorbidity is key to improving the management and outcomes of generalized anxiety disorder.